[
    [
        {
            "time": "",
            "original_text": "康龙化成：目前公司没有新冠疫苗业务，公司也没有参与新冠口服药的研发业务",
            "features": {
                "keywords": [
                    "康龙化成",
                    "新冠疫苗",
                    "新冠口服药",
                    "研发业务"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成：目前公司没有新冠疫苗业务，公司也没有参与新冠口服药的研发业务",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "康龙化成：目前公司没有新冠疫苗业务",
            "features": {
                "keywords": [
                    "康龙化成",
                    "新冠疫苗",
                    "业务"
                ],
                "sentiment_score": -0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康龙化成：目前公司没有新冠疫苗业务",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "干货！2021年中国医药研发外包(CRO)行业龙头企业分析——药明康德：行业中的“领军者”",
            "features": {
                "keywords": [
                    "医药研发外包",
                    "CRO",
                    "药明康德",
                    "龙头企业",
                    "领军者"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "干货！2021年中国医药研发外包(CRO)行业龙头企业分析——药明康德：行业中的“领军者”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]